The management of reaction in leprosy.
Reaction and the subsequent development of neuritis is the basis for the majority of the disabilities and deformities that occur in leprosy. All possible means to prevent, to treat, and to reverse every reaction should be employed in all-out effort to ultimately effect as ideal a functional status for the patient as can be attained.
Pfaltzgraff
R E
RE
Program and Training American Leprosy Missions, Elmwood Park, New Jersey 07407.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000917:Antibody Formation; D001241:Aspirin / Q000627:therapeutic use; D001557:Benzenesulfonates / Q000627:therapeutic use; D002738:Chloroquine / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007111:Immunity, Cellular; D007249:Inflammation / Q000209:etiology; D007918:Leprosy / Q000276:immunology* / Q000382:microbiology / Q000628:therapy; D013165:Splints; D013514:Surgical Procedures, Operative; D013792:Thalidomide / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001557:Benzenesulfonates; D013792:Thalidomide; D002738:Chloroquine; D002991:Clofazimine; D001241:Aspirin